China 99% Purity Retatrutide lyophilized powder

We supply APIs, pharmaceutical intermediates, and functional peptide materials for research, supporting everything from sample testing and small-batch trial orders to bulk procurement.

We offer:

COA and product specifications
Various specifications and packaging options
Bulk purchase quotes
International shipping and logistics tracking
Long-term, stable supply services
Contact Us

WhatsApp / Telegram:   +1 605 633 3333  

Email:   tail333398@gmail.com  

FAQ

Q: What is the minimum order quantity (MOQ)?
A: It depends on the product; the standard MOQ is usually 100g, though trial orders of 10g or 20g are available for some products.

Q: Can you provide samples?
A: Yes, free samples are available for some products (shipping costs are borne by the customer).

Q: Are there discounts for bulk orders?
A: Yes. Please provide the product name, quantity, and destination country, and we will provide an accurate quote.

Q: How soon will the order ship?
A: In-stock items usually ship within 1–3 business days after payment confirmation, and tracking information will be provided.

Q: How long does international shipping take?

A: Shipping time depends on the destination country and local delivery conditions. Generally, international shipping takes about 5–12 business days.

Q: What payment methods do you accept?
A: We accept T/T, Wise,  Zelle, USDT, BTC, etc.

Q: How do I place an order?
A: Please send us the product name, order quantity, specifications, and destination country; we will then confirm the price, stock availability, and shipping arrangements.

Retatrutide is a new type of multi-target peptide drug developed by Eli Lilly and Company of the United States, it is a triple receptor agonist of GLP-1R/GIPR/GCGR. Its core mechanism is to regulate the metabolic process by activating glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP) and glucagon (GCG) receptors at the same time, and is used for the treatment of obesity and type 2 diabetes.

Indications and Efficacy:

★ Obesity Treatment:

In the Phase II clinical trial, patients in the highest dose group (12 mg) lost an average of 24.2% weight after 48 weeks, and some patients lost more than 30%.

★ Metabolic Dysfunction-Associated Fatty Liver Disease (MASLD):

Retatrutide can reduce liver fat content by 86%, and more than 85% of patients achieve regression of liver steatosis.

★ Type 2 Diabetes:

Significantly reduce glycated hemoglobin (HbA1c) and improve blood sugar control.

★ Potential Cardiovascular Benefits:

Animal studies have shown that it may indirectly protect cardiovascular health by improving blood pressure and heart function, but further clinical verification is needed.

Company Profile:

Laboratory Display:

Modes of Transport:

Packaging Process:

Payment Methods: